跳至主要内容
临床试验/NCT02229487
NCT02229487已完成不适用

The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers

Ramathibodi Hospital1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2014年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
GLP-1 Levels in Response to Oral Glucose Tolerance Test

研究概览

简要总结

Hypothesis

  1. Prediabetes patients who have insufficient sleep will have worse glucose tolerance than those with normal sleep duration.
  2. Prediabetes patients with short sleep will have a delayed or reduced GLP-1 response to a standardized meal

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with prediabetes (HbA1c 5.7-6.4% or history of fasting plasma glucose 100-125 mg/dl) who receive medical care at Ramathibodi Hospital
  • Age 18 or older
  • Can understand Thai (speaking, listening and reading)
  • Agree to participate by written informed consent

排除标准

  • Those who depend on others for feeding (such as stroke patients)
  • Shift workers
  • History of congestive heart failure or low ejection fraction
  • Chronic obstructive pulmonary disease, end stage renal disease or chronic liver disease (AST or ALT > 3 times the upper limit of normal)
  • Use of medications: opioids/ narcotics , alpha blockers (prazosin, doxazosin, terazosin), clonidine, methyldopa, nitroglycerin
  • Patients with permanent pacemaker
  • History of previous stroke

研究组 & 干预措施

Normal Sleepers

Active Comparator

Prediabetes patients with normal sleep duration (7-8 hours/ night) as measured objectively

干预措施: Oral glucose tolerance (Other)

Short Sleepers

Experimental

Prediabetes patients with short sleep duration (<6 hours/night) as measured objectively

干预措施: Oral glucose tolerance (Other)

结局指标

主要结局

GLP-1 Levels in Response to Oral Glucose Tolerance Test

时间窗: 2 weeks

Prediabetes patients with and without short sleep will undergo an oral glucose tolerance test with measurement of GLP-1 levels

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sirimon Reutrakul

Associate Professor

Ramathibodi Hospital

研究点 (1)

Loading locations...

相似试验